The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
maqsood7 I thought I had you on filter from previous encounter, I am sure. Back you go. The only reason I am highlighted it is because you will go as quick as you arrived, churn out what many already know and repeat this multiple times per week. Any new readers, please stick with the official line from the company news.
The price action and sebsequent posting for me at least shows some sitting on the sidelines who either sold and then when the pre audit was announced, panicked and now use the excuse of placings etc, to get the weak to sell and they hoover up at these bargain levels. Use as much gamesnamship as possible.
Keep it up as it helps people like me to get closer to the final holding requirement. No going anywhere anytime soon. This is building nicely.
Agree very positive pre audit, and look forward to April 23 now. If it stays here or around here then it would be stupid not to pick up anymore (I speak for myself).
Not interested in the minute by minute trading on this share but for those that are you might want to look at the end of the day trades today especially. Someone is picking up in a big way for the last two days and sellers are feeding them.
Agree with you Jace, I am not prepared to let these go. Maybe I will just hand them on to the next generation and keep some for retirement! There is no price on something that can saves lives for one things and change lives on another matter.
No Greend100 its not 10% mate. It when you hit 1% each time above 3%. So in this case 7.52% was initially announced, but because 8% (being the next level above) was triggered to 8.02%, it had to be announced or at the time the current buying had stopped.
Not related to the above (well it might be) but 2.25m trade was announced for 1.79p at 16.37hrs. (roughly just above £40k).
One would have to establish for a FACT that there is indeed a sell. Has there been an RNS to confirm a sell? Do you confirm your view on the basis that the price rise has not risen in line with the current buying frequency?
So long as no confirmation of a large sell, everything on track. Its a fact that there is buying, and lots of it.
Would love to know why someone had to buy 10x100k between 13:41hrs and 13:49hrs? Not worried that it has not moved price because that is forgone conclusion that, that will be coming. Very healthy buying all day and not sure if Mr Lang has stopped his buying.
Bottom was 14:00hrs.
Hi Jace hope you are well mate. Yes slowly getting to the point of no return lower. You almost feel like you dont want it to go yet until you have added more. Each time you promise, "that's it no more!" but even Martin Lang has seen the light.
Dawn Coverley has gone from 13359042 to 17,048,137 which is a rise of 3,689,096.
Allan Miller has gone from 2025511 to 14,858,844 a rise of 12,833,333
Finally no trace of Martin Lang previously so that a new holding of 26,109,570. No record of them holding any before this announcement.
If my calculations are correct they have sold down 17,722,276 shares, and now hold 33,280,000 or 9.84%.
Excellent posts from m007j and also DaveTK. TP selling has given many the opportunity to add buckets at these low prices and depressed times by selling.
November 1st 2022
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies
https://am.jpmorgan.com/us/en/asset-management/adv/about-us/media/press-releases/jp-morgan-launches-new-life-sciences-private-capital-team-targeting-investments-in-innovative-healthcare-companies/
(courtesy of the above link) "Laurie H. Glimcher, M.D. was named President and CEO of the Dana-Farber Cancer Institute in 2016. She is also Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research. "
https://www.dana-farber.org/about-us/leadership/laurie-glimcher/
(courtesy of the above link) "A trailblazer in cancer research, Dr. Glimcher's research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature."
My own target for the end of Dec 23 is 4.65p based only on my own current holding and what I would want projection wise. Anything above that would be a bonus. Anything below that and if funds were available (which they will be) would be a further buying opportunity. Again this would be based on current business continuing its projected growth.
No idea if anyone is selling/buying and not really concerned if they are, and 359 days from now is a different scenario to 5 minutes of analysis based on a few large trades.
For Dec 24 will be happy with 6.8p. Again anything higher would be a personal project well ahead of schedule.
Fully disagree, I was here before the RTO, building a free position prior to it, by buying heavy prior to suspension, and then reducing through placing price hikes, but have added again since aggressively, and after two years there has been plenty of updates. It’s a business headed by a champion in cancer research with partnerships in China and the USA. We have been shafted price wise ONLY by short term holders and traders who will continue to be shafted for the rest of their lives unless they take responsibility for their own actions. Last year was meant to be the year of progression and it will continue into 2023 and beyond.
From what I see, it would have been profitable both ways. Had CIZ remained in the current agreement with SGSC and Conduit, they would have been paid royalties of 5% for their economic interest in the commercialisation of the AZD 1656.
However as far as I can gather in total CIZ has paid just over £2m in raised proceeds from shares subscribed either by Conduit or private investors.
The put option now technically puts a floor value of around £3.25m minimum, and so CIZ has the best of both worlds? They can hold on to the current deal and gain royalties or sell the put option for anything around £3.25m or north of that and take shares in Conduit when they list on the NASDAQ.
I can see why Dr Allan Syms says "I am delighted to secure this transaction with Conduit, which upon exercise of the Option, is intended to give Cizzle exposure to the entire portfolio of Conduit as a shareholder, and in due course provide listed securities which Cizzle will have flexibility to monetise. The consideration pursuant to the Option represents a significant premium to our investment in initially securing royalty rights in AZD1656."
https://www.dvmarketresearch.com/vietnam-tonic-water-market/
https://tophotel.news/country-overview-123-hotels-to-open-across-vietnam-infographic/
Top five hotel construction projects that commenced in Vietnam in Q2 2022
1. Cadia Qui Nhon Mixed-Use Development – $320m ...
2. Iron Market Commercial Complex – $242m ...
3. Crystal Holidays Harbor Van Don Tourism Resort and Entertainment Complex – $155m ...
4. Cat Linh Van Don luxury hotel and apartment complex – $150m ...
5. Courtyard by Marriott Quy Nhon Hotel – $50m
Hopefully a great first day and going forward and also great help to those that need it medically.